ACADIA PHARMACEUTICALS INC (ACAD) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-29

ACADIA PHARMACEUTICALS INC (ACAD) has filed 11 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-29. 3 Form 8-K material event filings were reported by ACAD in the last 90 days. 2 Form 144 notices of proposed sale were filed for ACAD stock. InsiderAlpha tracks every ACAD SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About ACADIA PHARMACEUTICALS INC (ACAD)

SEC CIK0001070494

90-Day SEC Filing Activity

Form 4 filings (90d)11
Form 8-K filings (90d)3
Form 144 notices (90d)2
Latest Form 4 filing2026-06-29

Recent ACAD Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
Kihara JamesPRINCIPAL ACCOUNTING OFFICERS — Open-market sale11.4K$26.08$298KSEC
Poole JonathanInsiderM — Option exercise2.0K——SEC
Daly James MInsiderM — Option exercise8.1K——SEC
BAKER BROS. ADVISORS LPInsiderA — Grant or award18.6K$0.00—SEC
BAKER BROS. ADVISORS LPInsiderA — Grant or award18.6K$0.00—SEC
HARRIGAN EDMUNDInsiderM — Option exercise8.1K——SEC
Brege LauraInsiderM — Option exercise8.1K——SEC
Ndu AdoraInsiderM — Option exercise8.1K——SEC
GAROFALO ELIZABETH A.InsiderM — Option exercise8.1K——SEC
Kihara JamesPRINCIPAL ACCOUNTING OFFICERS — Open-market sale5.4K$21.18$114KSEC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERS — Open-market sale3.5K$21.79$76KSEC
Kihara JamesPRINCIPAL ACCOUNTING OFFICERS — Open-market sale1.3K$21.79$29KSEC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERM — Option exercise6.8K——SEC
Kihara JamesPRINCIPAL ACCOUNTING OFFICERM — Option exercise2.6K——SEC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERS — Open-market sale [10b5-1]2.7K$22.20$60KSEC

All transactions sourced from SEC EDGAR Form 4 filings for ACADIA PHARMACEUTICALS INC (ACAD). Updated in real time as new filings are submitted to the SEC.

Most-Active ACAD Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
Kihara James5$441K
HARRIGAN EDMUND4—
Daly James M4—
GAROFALO ELIZABETH A.4—
Brege Laura4—

Recent ACAD Form 8-K Material Events

Recent ACAD Form 144 Notices of Proposed Sale

Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ACAD insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

ACAD Insider Trading — FAQ

What is the latest insider trade for ACAD?
ACADIA PHARMACEUTICALS INC (ACAD) had 11 insider filings in the last 90 days, with the most recent on 2026-06-29. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying ACAD stock?
0 insider purchases of ACAD were filed in the last 90 days.
How many insiders are selling ACAD stock?
0 insider sales of ACAD were filed in the last 90 days.
Where can I see ACAD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every ACAD SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live ACAD dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.